SG10201604676WA - Therapy for subarachnoid hemorrhage and ischemia - Google Patents
Therapy for subarachnoid hemorrhage and ischemiaInfo
- Publication number
- SG10201604676WA SG10201604676WA SG10201604676WA SG10201604676WA SG10201604676WA SG 10201604676W A SG10201604676W A SG 10201604676WA SG 10201604676W A SG10201604676W A SG 10201604676WA SG 10201604676W A SG10201604676W A SG 10201604676WA SG 10201604676W A SG10201604676W A SG 10201604676WA
- Authority
- SG
- Singapore
- Prior art keywords
- ischemia
- therapy
- subarachnoid hemorrhage
- subarachnoid
- hemorrhage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161570264P | 2011-12-13 | 2011-12-13 | |
| CA2762338A CA2762338C (en) | 2011-12-13 | 2011-12-15 | Therapy for subarachnoid hemorrhage and ischemia |
| US201261617001P | 2012-03-28 | 2012-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201604676WA true SG10201604676WA (en) | 2016-07-28 |
Family
ID=51228598
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201604676WA SG10201604676WA (en) | 2011-12-13 | 2012-12-13 | Therapy for subarachnoid hemorrhage and ischemia |
| SG11201403239UA SG11201403239UA (en) | 2011-12-13 | 2012-12-13 | Therapy for subarachnoid hemorrhage and ischemia |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201403239UA SG11201403239UA (en) | 2011-12-13 | 2012-12-13 | Therapy for subarachnoid hemorrhage and ischemia |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2800575B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP6279483B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20200057802A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104053448B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012354072B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2800575T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2731266T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL233103B (cg-RX-API-DMAC7.html) |
| MX (1) | MX364562B (cg-RX-API-DMAC7.html) |
| SG (2) | SG10201604676WA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013088382A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201404636B (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2765169C (en) | 2009-06-10 | 2019-06-18 | Nono Inc. | Model systems and treatment regimes for treatment of neurological disease |
| HRP20220519T1 (hr) | 2011-06-24 | 2022-05-27 | Nono Inc. | Kombinacijska terapija ishemije |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| PL3074032T3 (pl) * | 2013-12-01 | 2019-06-28 | University Of Copenhagen | Pochodne kwasów tłuszczowych dimerycznych inhibitorów psd-95 |
| UA123820C2 (uk) | 2014-05-28 | 2021-06-09 | Ноно Інк. | Хлоридна сіль пептиду tat-nr2b9c |
| CN107312071B (zh) * | 2016-04-27 | 2018-11-06 | 拜西欧斯（北京）生物技术有限公司 | 兴奋性神经毒性相关损伤的治疗方法 |
| US20190134150A1 (en) * | 2016-04-27 | 2019-05-09 | Biocells (Beijing) Biotech Co., Ltd. | Therapeutic methods for excitatory neurotoxicity-related injuries |
| CN109985047B (zh) * | 2017-12-29 | 2021-07-27 | 广州市赛普特医药科技股份有限公司 | 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用 |
| CN109009111A (zh) * | 2018-07-16 | 2018-12-18 | 重庆大学 | 低场核磁共振脑出血动态监护仪控制系统 |
| CN113284126B (zh) * | 2021-06-10 | 2022-06-24 | 安徽省立医院(中国科学技术大学附属第一医院) | 人工神经网络图像分析预测脑积水分流手术疗效的方法 |
| CN113735938B (zh) * | 2021-07-30 | 2024-11-08 | 英纳氏(珠海)药业有限公司 | 一种神经保护多肽化合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7510824B2 (en) | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
| EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
| ES2446292T3 (es) * | 2007-03-02 | 2014-03-07 | Nono Inc. | Tratamiento del accidente cerebrovascular y otras enfermedades sin inhibir los canales de calcio de tipo N |
| CA2765169C (en) * | 2009-06-10 | 2019-06-18 | Nono Inc. | Model systems and treatment regimes for treatment of neurological disease |
-
2012
- 2012-12-13 AU AU2012354072A patent/AU2012354072B2/en not_active Ceased
- 2012-12-13 CN CN201280061924.1A patent/CN104053448B/zh not_active Expired - Fee Related
- 2012-12-13 WO PCT/IB2012/057259 patent/WO2013088382A1/en not_active Ceased
- 2012-12-13 MX MX2014007031A patent/MX364562B/es active IP Right Grant
- 2012-12-13 ES ES12857611T patent/ES2731266T3/es active Active
- 2012-12-13 DK DK12857611.3T patent/DK2800575T3/da active
- 2012-12-13 JP JP2014546717A patent/JP6279483B2/ja not_active Expired - Fee Related
- 2012-12-13 EP EP12857611.3A patent/EP2800575B1/en active Active
- 2012-12-13 KR KR1020207014227A patent/KR20200057802A/ko not_active Ceased
- 2012-12-13 KR KR1020147019192A patent/KR102114490B1/ko not_active Expired - Fee Related
- 2012-12-13 SG SG10201604676WA patent/SG10201604676WA/en unknown
- 2012-12-13 SG SG11201403239UA patent/SG11201403239UA/en unknown
-
2014
- 2014-06-12 IL IL233103A patent/IL233103B/en active IP Right Grant
- 2014-06-24 ZA ZA2014/04636A patent/ZA201404636B/en unknown
-
2017
- 2017-11-10 JP JP2017217549A patent/JP6741642B2/ja not_active Expired - Fee Related
-
2020
- 2020-05-15 JP JP2020085748A patent/JP2020128419A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020128419A (ja) | 2020-08-27 |
| CN104053448B (zh) | 2017-04-05 |
| JP6279483B2 (ja) | 2018-02-14 |
| JP6741642B2 (ja) | 2020-08-19 |
| JP2015501834A (ja) | 2015-01-19 |
| AU2012354072B2 (en) | 2017-04-27 |
| JP2018052962A (ja) | 2018-04-05 |
| IL233103A0 (en) | 2014-07-31 |
| AU2012354072A1 (en) | 2014-07-03 |
| ES2731266T3 (es) | 2019-11-14 |
| DK2800575T3 (da) | 2019-07-01 |
| KR20200057802A (ko) | 2020-05-26 |
| WO2013088382A1 (en) | 2013-06-20 |
| MX364562B (es) | 2019-04-30 |
| KR102114490B1 (ko) | 2020-05-25 |
| MX2014007031A (es) | 2015-02-20 |
| SG11201403239UA (en) | 2014-09-26 |
| EP2800575A4 (en) | 2015-09-23 |
| CN104053448A (zh) | 2014-09-17 |
| ZA201404636B (en) | 2015-10-28 |
| KR20140108266A (ko) | 2014-09-05 |
| EP2800575A1 (en) | 2014-11-12 |
| EP2800575B1 (en) | 2019-05-22 |
| IL233103B (en) | 2021-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201404636B (en) | Therapy for subarachnoid hemorrhage and ischemia | |
| EP2739221A4 (en) | SURGICAL ANCHOR | |
| EP2739144A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
| PL2723363T3 (pl) | Leczenie skojarzone niedokrwienia | |
| ZA201309056B (en) | Surgical fastening | |
| ZA201305897B (en) | Combination therapy | |
| GB201212513D0 (en) | Therapeutic agents | |
| ZA201403372B (en) | Therapeutic agents and uses thereof | |
| GB201114212D0 (en) | Therapeutic agents | |
| PT2744797E (pt) | Inibidores de dyrkl e suas utilizações | |
| ZA201400120B (en) | Combination therapy | |
| GB201119401D0 (en) | Therapeutic agents | |
| EP2761524A4 (en) | SAFE DISPLAYS FOR SAFE TRANSACTIONS | |
| IL229303A0 (en) | Devices and methods to fasten tissue | |
| PL2723330T3 (pl) | Lek kombinowany zawierający środek naczynioskurczowy | |
| GB201217704D0 (en) | Therapeutic agents | |
| EP2701744A4 (en) | COMBINATION THERAPY | |
| SG11201404121TA (en) | Device for cold therapy | |
| GB201101128D0 (en) | Therapeutic agents | |
| GB201115558D0 (en) | Therapeutic agents | |
| GB201110614D0 (en) | Therapeutic agents | |
| GB201214985D0 (en) | Modified therapeutic agents | |
| GB201213712D0 (en) | Modified therapeutic agents | |
| GB201110895D0 (en) | Therapeutic use | |
| GB201010577D0 (en) | Therapeutic agents |